Asthma & COPD Mastery Guide

🩺 Asthma & COPD Mastery Guide

Chronic Care, Perioperative Optimization, and Critical Management

🔷 About This Guide

Prepared for Dr. Amir Fadhel — Specialist in Anesthesiology and Critical Care
This clinical teaching guide was developed in collaboration with Sophia (ChatGPT-4o) as part of an evolving educational series supporting students, anesthesia technicians, residents, and ICU professionals in both advanced and resource-limited settings.

This guide focuses on the comprehensive management of Asthma and Chronic Obstructive Pulmonary Disease (COPD) — from outpatient care and pharmacology, to anesthesia planning and perioperative safety, to emergency airway crises and intensive care strategies.

It builds on the same format and educational principles used in our previous series:

🔹 ABG Interpretation Guide
🔹 Shock Mastery Guide
🔹 Mechanical Ventilation in the ICU
🔹 ARDS Mastery Guide
🔹 ICU Daily Rounds & FAST HUG BID
🔹 Oxygen Therapy Mastery Guide
🔹 OR Ventilation (Anesthesia Machine) Mastery Guide
🔹 Sepsis Mastery Guide
🔹 Delirium & Sedation Mastery Guide
🔹 Neonatal RDS & Respiratory Support Guide

As always, while these materials are evidence-based and curated through expert discussions, they are not a substitute for clinical judgment, updated guidelines, or textbook reading.

📚 Contents

1️⃣ Introduction & Definitions
2️⃣ Pathophysiology: Asthma vs. COPD
3️⃣ Chronic Medical Management
4️⃣ Preoperative Assessment & Optimization
5️⃣ Anesthesia Considerations
6️⃣ Emergency Presentations & Management
7️⃣ ICU Management of Asthma & COPD
8️⃣ Special Considerations (Status Asthmaticus, CO₂ Retainers, etc.)
9️⃣ Pocket Guide & Clinical Pearls
🔟 MCQ Bank (15 Questions with Explanations)
🔚 Final Words

✅ Section 1: Introduction & Definitions

🔹 Asthma: Definition & Characteristics

Asthma is a chronic inflammatory airway disease characterized by:

Reversible airway obstruction
Airway hyperresponsiveness (AHR)
Episodic symptoms: wheezing, breathlessness, chest tightness, and cough

Common triggers:

Allergens (dust, pollen, pets)
Cold air, exercise
Respiratory infections
Irritants (smoke, perfumes)

🧠 Key Point: Unlike COPD, asthma obstruction is usually completely or partially reversible with bronchodilators or corticosteroids.

🔹 COPD: Definition & Characteristics

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease involving:

Irreversible airflow limitation
Chronic bronchitis and/or emphysema
Associated with smoking, biomass exposure, or environmental pollutants

Symptoms:

Chronic productive cough
Exertional dyspnea
Wheezing and fatigue
Frequent respiratory infections

🧠 Key Point: COPD patients often develop dynamic hyperinflation, air trapping, and CO₂ retention — particularly relevant for anesthesia and ICU management.

🔍 Comparing Asthma and COPD

Feature	Asthma	COPD
Onset	Childhood or early adulthood	After age 40
Reversibility	Reversible	Largely irreversible
Inflammatory Cells	Eosinophils	Neutrophils
Night/early symptoms	Common	Less common
Smoking history	Not essential	Usually present
Airflow limitation	Intermittent	Progressive and persistent
DLCO	Normal or high	Reduced

✅ Section 2: Pathophysiology — Asthma vs. COPD

Understanding the underlying pathophysiology is essential for differentiating treatment, anticipating complications, and planning safe anesthesia or ICU strategies.

🔹 Asthma Pathophysiology

Asthma is primarily an inflammatory disease of the airways with:

Hyperreactivity to stimuli (cold air, allergens, exercise)
Bronchoconstriction (smooth muscle contraction)
Airway edema and mucus hypersecretion
Airway remodeling in chronic cases

🧪 Inflammatory Profile:

Dominated by Th2 lymphocytes
Eosinophils, mast cells, and cytokines (IL-4, IL-5, IL-13)
Reversible airflow limitation

🔍 Resulting Physiologic Effects:

Increased airway resistance (RAW)
↓ Peak expiratory flow rate (PEFR)
V/Q mismatch → Hypoxemia
Normal or low PaCO₂ in early attacks
⚠️ Rising PaCO₂ in asthma = impending respiratory failure

🔹 COPD Pathophysiology

COPD is a chronic, progressive, destructive disease involving: 1️⃣ Chronic Bronchitis — inflammation of large airways
2️⃣ Emphysema — destruction of alveolar walls and loss of elastic recoil

🧪 Inflammatory Profile:

Dominated by neutrophils, macrophages, CD8+ T cells
Structural changes: goblet cell hyperplasia, fibrosis, ciliary dysfunction
Irreversible airflow limitation due to loss of alveolar support and airway collapse

🔍 Resulting Physiologic Effects:

Air trapping and dynamic hyperinflation
↑ Functional Residual Capacity (FRC), ↓ Inspiratory Reserve Volume (IRV)
V/Q mismatch, shunt physiology
Chronic hypoxemia and hypercapnia
Pulmonary hypertension → Cor pulmonale

📌 Key Pathophysiologic Differences

Feature	Asthma	COPD
Primary Problem	Bronchial hyperresponsiveness	Alveolar destruction + mucus
Reversibility	Yes	Minimal
Inflammatory Cells	Eosinophils, Th2	Neutrophils, macrophages
Compliance	Normal	Increased (loss of elasticity)
Diffusion Capacity (DLCO)	Normal or ↑	↓ (especially in emphysema)
PaCO₂ in Exacerbation	Often ↓ or normal (early)	Often ↑ (CO₂ retention)
Airway Resistance	High during attacks	Persistently high
Response to Bronchodilators	Good	Partial

💡 Clinical Tip

In COPD, expiratory airflow limitation is key. These patients need longer expiratory times during ventilation (e.g., I:E ratio of 1:3 or 1:4).
In asthma, avoid dynamic hyperinflation and closely monitor rising PaCO₂ as a red flag for exhaustion and possible need for intubation.

✅ Section 3: Chronic Medical Management

GOLD (COPD) & GINA (Asthma) Guidelines in Practice

Effective long-term management is essential to reduce symptoms, prevent exacerbations, and optimize preoperative and critical care outcomes.

📚 What Are GINA and GOLD?

To standardize care, two globally recognized expert groups regularly update guidelines for asthma and COPD:

🔹 GINA – Global Initiative for Asthma

A scientific body formed by WHO and NHLBI (U.S. National Heart, Lung, and Blood Institute)
Publishes annual evidence-based strategies for:
- Diagnosis
- Stepwise treatment
- Risk reduction
- Inhaler use and prevention of exacerbations
Target: Asthma in all age groups

🔹 GOLD – Global Initiative for Chronic Obstructive Lung Disease

A global collaboration of specialists supported by NIH and WHO
Focuses exclusively on COPD diagnosis and management
Publishes:
- ABCD → ABE grouping strategy
- Evidence for bronchodilators, steroids, and risk stratification
- Long-term care models and updates for inhaler therapy

🧠 Note: Both GINA and GOLD stress individualized therapy, avoidance of overreliance on SABA, and the importance of education, adherence, and follow-up.

🧩 Before diving into guideline-based step therapy, it’s essential to understand the core drug classes repeatedly referenced in both asthma (GINA) and COPD (GOLD) frameworks.

These inhaled medications form the foundation of chronic respiratory disease management. Their classification is based on:

Mechanism of action (e.g., beta-2 agonists vs. antimuscarinics)
Duration of effect (short-acting vs. long-acting)
Anti-inflammatory vs. bronchodilatory role

The most frequently used acronyms — SABA, LABA, ICS, LAMA, and SAMA — represent specific drug categories used alone or in combination.

Understanding these is crucial for interpreting stepwise treatment plans, choosing appropriate combinations, and safely managing patients across all clinical settings.

➡️ Let’s now review each of these classes in detail.

🔍 Understanding SABA, LABA, ICS, LAMA - Key to Guideline-Based Therapy

These terms — SABA, LABA, ICS, LAMA — are core pillars of asthma and COPD treatment. Here's a breakdown for students, technicians, and clinicians alike:

1️⃣ SABA – Short-Acting Beta-2 Agonists

Mechanism: Stimulates β2 receptors → bronchodilation within minutes
Onset: Fast (within 5 minutes)
Duration: 4–6 hours
Use: Acute symptom relief (“rescue inhaler”)

Examples:

Salbutamol (Albuterol)
Levosalbutamol

🧠 Note: Overuse signals poor control; should not be the only medication in persistent asthma.

2️⃣ LABA – Long-Acting Beta-2 Agonists

Mechanism: Same as SABA but longer action
Duration: ~12–24 hours
Use: Maintenance therapy (never alone in asthma!)

Examples:

Salmeterol
Formoterol (also has a fast onset — used PRN in GINA 2024)
Indacaterol (mainly COPD)

🧠 Caution: In asthma, LABA must be paired with ICS to prevent worsening inflammation or death.

3️⃣ ICS – Inhaled Corticosteroids

Mechanism: Anti-inflammatory — suppresses eosinophilic inflammation
Use: Backbone of asthma control; added in eosinophilic COPD

Examples:

Budesonide
Fluticasone
Beclomethasone

🧠 Tip: Rinse mouth after use to avoid oral candidiasis.

4️⃣ LAMA – Long-Acting Muscarinic Antagonists

Mechanism: Blocks muscarinic (M3) receptors → bronchodilation
Use: Mainstay in COPD, and added in severe asthma

Examples:

Tiotropium
Aclidinium
Glycopyrronium

🧠 Effect: Improves lung function, reduces exacerbations and hospitalizations.

5️⃣ SAMA – Short-Acting Muscarinic Antagonists

Example: Ipratropium bromide
Use: Acute bronchodilation, often combined with SABA in ER or ICU

6️⃣ Combination Inhalers

To simplify inhaler regimens and improve adherence:

Type	Example	Use
ICS + LABA	Budesonide + Formoterol (Symbicort)	Asthma & COPD maintenance
LABA + LAMA	Indacaterol + Glycopyrronium	COPD maintenance
ICS + LABA + LAMA	Fluticasone + Umeclidinium + Vilanterol (Trelegy)	Severe COPD or overlap

🧪 Summary Table

Class	Full Name	Action	Duration	Main Use
SABA	Short-acting β₂-agonist	Fast bronchodilation	4–6 hrs	Rescue
LABA	Long-acting β₂-agonist	Sustained bronchodilation	12–24 hrs	Maintenance
ICS	Inhaled corticosteroid	Anti-inflammatory	Maintenance	Asthma & overlap
LAMA	Long-acting muscarinic antagonist	Bronchodilation	~24 hrs	COPD backbone
SAMA	Short-acting muscarinic antagonist	Fast relief	4–6 hrs	Acute COPD/asthma

📌 When Doses Matter

We’ll include precise doses and routes (inhaled, nebulized, IV, IM) during:

Emergency presentations (status asthmaticus, COPD exacerbation)
ICU management (bronchodilator regimens, IV steroids, magnesium sulfate)
Perioperative periods (pre-op optimization protocols)

🔷 Asthma – Stepwise Treatment (GINA Guidelines)

Management is based on control level, using a stepwise approach:

🪜 Stepwise Treatment Summary

Step	Medications	Indication
1️⃣	As-needed low-dose ICS-formoterol	Intermittent symptoms
2️⃣	Daily low-dose ICS or PRN ICS-formoterol	Persistent symptoms
3️⃣	Low-dose ICS + LABA	Poor control or frequent reliever use
4️⃣	Medium-dose ICS + LABA	Severe symptoms or exacerbations
5️⃣	High-dose ICS + LABA ± LAMA, anti-IgE/IL5/IL4	Severe, uncontrolled asthma

🧠 Key Concepts:

PRN ICS-formoterol is preferred over SABA alone.
Inhaler technique and adherence are critical.
Consider step-down once good control is maintained for 3 months.

🔷 COPD – GOLD ABCD to ABE Assessment (2023 Update)

The GOLD system classifies patients based on exacerbation history and symptom burden (e.g., CAT or mMRC scores).

📊 Treatment by GOLD Category

Group	Treatment	Notes
A	Bronchodilator (SABA or LABA/LAMA)	Mild symptoms, low risk
B	LABA or LAMA	High symptoms, low risk
E	LAMA or LAMA + LABA or LABA + ICS	Frequent exacerbations

🧠 Key Concepts:

LAMA is superior to LABA in reducing exacerbations.
Add ICS only if:
- Blood eosinophils >300 cells/µL
- Asthma-COPD overlap
- Frequent exacerbations despite LABA/LAMA

🔄 Triple Therapy (ICS + LABA + LAMA) is reserved for severe or frequent exacerbations.

🫁 Common Inhaler Classes

Drug Class	Examples	Use
SABA	Salbutamol (albuterol)	Acute relief, all patients
LABA	Salmeterol, Formoterol	Maintenance therapy (Asthma + COPD)
ICS	Budesonide, Fluticasone	Asthma cornerstone, some COPD cases
LAMA	Tiotropium, Glycopyrronium	COPD mainstay, add in severe asthma
ICS/LABA	Budesonide/Formoterol	Main combo for asthma & severe COPD
Triple Rx	ICS + LABA + LAMA (e.g. Trelegy)	Severe COPD or overlap asthma-COPD

💡 Practical Tips for Clinics & Rural Practice

🔹 Educate on correct inhaler technique — use spacers if needed.
🔹 Reinforce daily use, not just symptom-driven use.
🔹 Screen and address comorbidities: GERD, obesity, anxiety, OSA.
🔹 Ensure annual influenza and pneumococcal vaccination.
🔹 Consider home pulse oximetry or spirometry for follow-up.

✅ Section 4: Preoperative Assessment & Optimization

Asthma & COPD Patients Undergoing Surgery

🔷 Why It Matters

Patients with asthma or COPD are at higher risk of:

Bronchospasm during induction or emergence
Prolonged intubation and ventilator support
Postoperative pulmonary complications (PPCs)
ICU admission and delayed recovery

Proper preoperative evaluation and optimization can reduce morbidity and improve surgical outcomes.

🔍 Stepwise Preoperative Approach

1️⃣ Detailed History

Age at diagnosis, frequency of symptoms
Recent exacerbations or hospitalizations
Triggers, home oxygen use, steroid use
Functional status: mMRC or CAT score
Compliance with inhalers
Prior intubations or ICU admissions

🧠 Ask: “When was your last exacerbation?” “Do you use inhalers every day or only when breathless?”

2️⃣ Physical Exam & Red Flags

Look for:

Active wheezing or prolonged expiration
Use of accessory muscles
Baseline oxygen saturation
Clubbing, signs of cor pulmonale (JVD, edema)

🛑 Defer elective surgery if acute infection, decompensated symptoms, or recent exacerbation <6 weeks.

3️⃣ Pulmonary Function Testing (If Available)

FEV₁ < 50% predicted = ↑ PPC risk
PEFR < 80% baseline = poor control
Bronchodilator response = asthma > COPD
ABG if patient has dyspnea at rest, cyanosis, or CO₂ retention history

📎 If no spirometry available, base decisions on symptoms, SpO₂, and clinical history.

4️⃣ Preoperative Labs & Imaging

CBC: Eosinophilia (asthma), anemia
Chest X-ray: Rule out infection or hyperinflation
ECG & Echo: If cor pulmonale or hypoxia suspected
ABG: If altered mental status or baseline CO₂ retention

5️⃣ Optimization Strategy Before Surgery

Goal	Action
Relieve bronchospasm	Nebulized SABA/SAMA (salbutamol + ipratropium)
Reduce inflammation	Oral or IV corticosteroids (e.g., prednisone 40 mg x 5–7 days)
Mucus clearance	Hydration, physiotherapy, mucolytics if needed
Prevent triggers	Avoid smoking, allergens, cold exposure
Inhaler compliance	Ensure patient using controller medications properly
Infection control	Treat active LRTIs, delay elective surgery if present
Oxygenation	Target SpO₂ > 92%; consider home O₂ plan

🧠 Asthma: Add Montelukast in moderate–severe disease
🧠 COPD: Use LABA/LAMA combo before surgery if not already on

💉 Steroids and Anesthesia

Patients on chronic steroids (>10 mg/day prednisone) may need:

Stress-dose steroids (e.g., hydrocortisone 100 mg IV pre-induction + q8h for 24h)
Monitor for hyperglycemia, delayed wound healing

📋 Day of Surgery Checklist

✅ No active wheeze
✅ Pre-op bronchodilators given
✅ Bring patient’s own inhalers to OR
✅ Avoid sedatives that depress respiratory drive
✅ Plan for possible post-op ICU or non-invasive ventilation (NIV)
✅ Communicate with anesthesia about status and plan

🧠 Clinical Tip

If patient cannot perform spirometry, ask:

“How many stairs can you climb before stopping?”
“Can you lie flat without gasping?”
“Have you needed ER/nebulizer in the last month?”

This functional assessment guides pre-op risk in rural or limited-resource settings.

✅ Section 5: Anesthesia Considerations in Asthma & COPD

Patients with asthma and COPD present unique perioperative challenges due to reactive airways, airflow limitation, and potential CO₂ retention. Proper planning reduces intraoperative complications, ventilator dependence, and postoperative pulmonary morbidity.

🔷 Key Goals of Anesthetic Management

Prevent bronchospasm or airway irritation
Maintain adequate oxygenation and ventilation
Avoid dynamic hyperinflation and air trapping
Choose agents that minimize respiratory depression
Tailor the approach to the patient’s baseline control and disease type

🧠 General Principles

Factor	Asthma	COPD
Airway reactivity	High	Less reactive, more collapsible
Reversibility	Reversible obstruction	Irreversible airflow limitation
CO₂ retention risk	Lower (unless status asthmaticus)	High, especially in advanced stages
Preferred ventilation	Volume or pressure control with prolonged expiration	Pressure control with longer I:E ratio

1️⃣ Pre-Induction Preparation

Continue inhaled bronchodilators on the day of surgery
If poorly controlled:
- Nebulize with SABA + SAMA 30–60 min before OR
- Administer IV corticosteroids (e.g., hydrocortisone 100 mg)
Avoid exposure to cold air, irritants, or unfiltered gases
Consider humidified oxygen pre-induction

🛑 Do not sedate heavily if the patient has active wheeze or known CO₂ retention.

2️⃣ Choice of Anesthetic Agents

🔹 Induction

Agent	Notes
Propofol	Ideal — suppresses airway reflexes, bronchodilator
Etomidate	Good for unstable patients, no histamine release
Ketamine	Bronchodilator effect, especially in asthma crisis
Thiopental	Avoid — may cause histamine release and bronchospasm

🧠 Ketamine is preferred in active bronchospasm or status asthmaticus.

🔹 Neuromuscular Blocking Agents (NMBAs)

Agent	Safety
Rocuronium	Safe, non-histamine-releasing
Atracurium	Acceptable, but may cause mild histamine release
Succinylcholine	Acceptable; watch for fasciculations in reactive airways

Avoid Mivacurium and Histamine-releasing agents in asthmatics.

🔹 Maintenance Anesthesia

Agent	Use in Asthma	Use in COPD
Sevoflurane	Best — bronchodilator	Good — low airway irritation
Isoflurane	Less preferred — airway irritant	Acceptable if no Sevoflurane
Desflurane	Avoid — may trigger bronchospasm	Not suitable
TIVA (Propofol)	Excellent in both — minimal airway reaction	Useful in severe COPD or ventilator-dependent patients

🧠 In resource-limited settings, Ketamine + Isoflurane may be the safest choice for asthmatic patients.

3️⃣ Intraoperative Ventilation Strategies

🔹 Asthma:

Low tidal volume (6–8 mL/kg)
Low RR (10–12 bpm)
Prolonged expiration: I:E = 1:3 or more
Permissive hypercapnia is acceptable

🔹 COPD:

Avoid high FiO₂ in CO₂ retainers
Use PEEP cautiously (4–5 cmH₂O)
Monitor for auto-PEEP and dynamic hyperinflation
Adjust I:E to 1:3 or 1:4 to allow full expiration
Target TV ~6 mL/kg, RR 10–12 bpm

📌 Capnography and flow-volume loops help identify air trapping and breath stacking.

4️⃣ Emergence and Extubation

Ensure complete reversal of neuromuscular blockade
Deep extubation may be considered in controlled asthmatics to reduce coughing
Suction only under deep anesthesia to avoid laryngospasm
Administer SABA or nebulized bronchodilator 15–30 min before extubation
Monitor SpO₂ and EtCO₂ closely post-extubation

🧠 Avoid emergence agitation — it increases oxygen demand and worsens dynamic hyperinflation.

5️⃣ High-Risk Situations

Scenario	Action
Recent COPD exacerbation	Delay surgery if possible
Status asthmaticus	Resuscitate fully before OR; consider ICU pre-op
Long-term steroid therapy	Give stress-dose steroids intraop
Active wheezing or SpO₂ < 90%	Treat with bronchodilators, steroids; reassess fitness for surgery

📌 Practical Reminders for OR Teams

✅ Have bronchodilators and suction ready
✅ Avoid histamine-releasing drugs
✅ Communicate closely with recovery/ICU team
✅ Consider post-op NIV for moderate-severe COPD
✅ Plan for ICU transfer in high-risk patients

✅ Section 6: Emergency Presentations & Acute Management

Asthma Attacks & COPD Exacerbations in ER and ICU Settings

Emergencies in asthma and COPD can rapidly become life-threatening. Immediate recognition and tiered intervention are crucial — especially where resources are limited and delays in escalation can lead to cardiac arrest or need for prolonged ventilation.

🆘 Acute Severe Asthma (Status Asthmaticus)

📋 Diagnostic Criteria

Incomplete response to SABA
Speaking in words only
RR > 30/min, HR > 120/min
SpO₂ < 92%
Use of accessory muscles
Silent chest = ominous sign
Rising PaCO₂ = respiratory muscle fatigue

🚨 Management – Stepwise Approach

Step	Treatment	Notes
1️⃣	O₂ via NRB mask – Target SpO₂ > 94%	Consider ABG if CO₂ retention suspected
2️⃣	SABA (Salbutamol) nebulized q20 min	Add Ipratropium (SAMA) in first 3 doses
3️⃣	Systemic corticosteroids – IV/PO	e.g., Methylprednisolone 60–125 mg IV or Prednisone 40–60 mg PO
4️⃣	Magnesium sulfate 2 g IV over 20 min	Especially in refractory cases; smooth muscle relaxation
5️⃣	Subcutaneous adrenaline (0.3–0.5 mg IM)	If severe or near arrest; watch HR/BP
6️⃣	Ketamine IV infusion or bolus	0.5–1 mg/kg bolus or 0.5 mg/kg/h – bronchodilator + sedation
7️⃣	Intubation only if impending arrest	Use Ketamine + Rocuronium; gentle ventilation (see below)

🧠 Avoid sedatives and opioids unless intubating — they depress respiratory drive.

🔒 Intubation Strategy in Asthma

Modified RSI: Ketamine + Rocuronium (avoid thiopentone, use lidocaine premed)
Manual bag gently with long expiratory phase
Post-intubation:
- Volume control
- RR 8–10
- TV 6 mL/kg
- I:E 1:4
- Permissive hypercapnia is acceptable
- Avoid auto-PEEP and barotrauma

🧯 Always check for dynamic hyperinflation and allow time for passive exhalation.

🌫️ Acute COPD Exacerbation

🩺 Signs

Worsening dyspnea
Increased sputum volume or purulence
Cough, fatigue, altered sensorium
CO₂ retention with acidosis (drowsiness = red flag)
Wheezing, hyperinflated chest

💊 Management – Stepwise

Step	Treatment	Notes
1️⃣	O₂ via Venturi or nasal cannula (88–92%)	Avoid high FiO₂ → suppresses respiratory drive
2️⃣	Nebulized bronchodilators (SABA ± SAMA)	Salbutamol + Ipratropium, q1h initially
3️⃣	Systemic steroids – IV or PO	e.g., Methylprednisolone 40–80 mg/day
4️⃣	Antibiotics if purulent sputum or infection signs	Doxycycline or Ceftriaxone + Azithromycin
5️⃣	Non-invasive ventilation (NIV) if acidotic	Improves CO₂ clearance; lowers intubation risk
6️⃣	Intubation only if NIV fails or severe encephalopathy	Use gentle settings; avoid breath stacking

🧠 Target pH > 7.25 and avoid aggressive correction of CO₂ — slow improvement is safer.

🔄 NIV in COPD Exacerbation

Mode: BiPAP
Initial settings:
- IPAP: 10–15 cmH₂O
- EPAP: 4–5 cmH₂O
- FiO₂: Titrate to SpO₂ 88–92%
Monitor RR, tidal volume, pH, and comfort

⚠️ When to Intubate in COPD

Refractory acidosis: pH < 7.25 despite NIV
Respiratory arrest or coma
Severe agitation, uncontrolled secretions
Intolerance or contraindication to NIV

🧠 Clinical Tips

Asthma + silent chest + rising CO₂ = emergency intubation
COPD + somnolence = likely CO₂ narcosis — trial of NIV unless crashing
Do not paralyze COPD patients unless necessary — they need time to trigger

✅ Section 7: ICU Management of Asthma & COPD

From Stabilization to Weaning – Strategies for Critical Care

Asthma and COPD patients in the ICU require careful balance between ventilatory support, anti-inflammatory therapy, and monitoring for complications such as barotrauma, mucus plugging, or ventilator-associated infections.

🔷 ICU Asthma Management

🚑 Admission Criteria

Status asthmaticus unresponsive to ED measures
Intubated patients post-cardiac arrest or near-failure
Persistent respiratory acidosis, rising PaCO₂
Refractory hypoxemia or fatigue

🛠️ Ventilator Strategy

Parameter	Setting in Intubated Asthmatic
Mode	Volume control (VCV) or Pressure control (PCV)
Tidal Volume (TV)	6 mL/kg ideal body weight
RR	8–10/min
I:E Ratio	1:3 to 1:5
FiO₂	Titrate to SpO₂ > 92%
PEEP	Minimal (3–5 cmH₂O) to avoid air trapping
Plateau Pressure	Keep < 30 cmH₂O
Permissive Hypercapnia	Acceptable if pH > 7.2

🔄 Allow full expiration and use long expiratory hold to measure auto-PEEP.

💊 ICU Medications

Nebulized bronchodilators: q1–2 hrs then spaced
IV steroids: Methylprednisolone 60–80 mg/day
Ketamine infusion: 0.5 mg/kg bolus → 0.5–1 mg/kg/hr (if ventilated)
Magnesium sulfate: 2 g IV once
Deep sedation (Propofol, Fentanyl) if paralyzed or asynchronous

⚠️ Complications to Monitor

Air leak syndromes: pneumothorax, pneumomediastinum
Mucus plugging → suction regularly
Ventilator asynchrony → adjust mode or sedate
Post-intubation hypotension → dynamic hyperinflation?

🧠 Bronchoscopic suctioning may be needed in thick secretions or atelectasis.

🔷 ICU COPD Management

🚑 Admission Criteria

Failed trial of NIV
Severe respiratory acidosis (pH < 7.25)
Hypoxic encephalopathy or drowsiness
Cardiovascular instability
Recurrent hypercapnic exacerbations needing close monitoring

🛠️ Ventilator Strategy

Parameter	Setting in Intubated COPD
Mode	Pressure control or volume assist-control
TV	6–8 mL/kg
RR	10–12/min
I:E Ratio	1:3 to 1:4
PEEP	4–5 cmH₂O (match or slightly exceed auto-PEEP)
FiO₂	Target SpO₂ 88–92%
Plateau Pressure	< 30 cmH₂O

🧠 Always monitor for breath stacking and high intrinsic PEEP.

💊 ICU Medications

Nebulized bronchodilators: Salbutamol + Ipratropium q4–6 hrs
Systemic steroids: Methylprednisolone 40–60 mg IV
Antibiotics: If purulence or infection present
Mucolytics, hydration, and suctioning
Low-dose sedatives (avoid over-sedation)

🧠 Weaning Strategy

Step	Approach
Spontaneous Breathing Trial (SBT)	Use with low PSV and PEEP (5/5); monitor RR, VT, comfort
Monitor for CO₂ buildup	ABG or transcutaneous CO₂ monitoring
Avoid re-intubation risk	Delay extubation if secretions are thick or cough is weak
Use post-extubation NIV	For COPD patients with CO₂ retention or high work of breathing

📌 ICU Pearls

Use Bronchodilator MDI with spacer in ventilated patients if nebulizers not available
In COPD, maintain mild permissive hypercapnia — don't chase “normal” PaCO₂
Avoid excessive sedation to maintain spontaneous efforts
Physiotherapy and early mobilization reduce ICU stay

📊 ICU Management: Asthma vs. COPD – Comparison Table

Feature	Asthma (Status Asthmaticus)	COPD Exacerbation
Primary Issue	Bronchospasm, airway inflammation	Air trapping, CO₂ retention, bronchial collapse
Reversibility	Typically reversible	Irreversible or partially reversible
Onset	Sudden, often triggered (allergen, exercise)	Gradual worsening, triggered by infection/pollution
Ventilation Mode	Volume or pressure control	Pressure control or assist-control
Tidal Volume	6 mL/kg	6–8 mL/kg
Respiratory Rate	8–10 breaths/min	10–12 breaths/min
I:E Ratio	1:3 to 1:5	1:3 to 1:4
PEEP Setting	Low (3–5 cmH₂O)	Match auto-PEEP (4–5 cmH₂O)
Permissive Hypercapnia	Accepted (if pH > 7.2)	Accepted, but monitor CO₂ narcosis
Bronchodilators	SABA + SAMA nebulized frequently	SABA + SAMA, spaced 4–6 hourly
Steroids	High-dose IV (e.g., Methylpred 60–80 mg/day)	Moderate-dose IV (e.g., Methylpred 40–60 mg/day)
Magnesium Sulfate	Yes, often used early (2 g IV)	Rarely used
Ketamine	Bronchodilator + sedative of choice	Used cautiously, mainly if sedative needed
NIV Role	Limited, not often helpful in severe asthma	First-line for moderate-severe exacerbation
Air Leak Risk	High (barotrauma, pneumothorax)	Present, especially with overventilation
Sedation Needs	Often deep sedation (e.g., Propofol, Ketamine)	Light sedation preferred to preserve drive
Post-extubation Support	Often wean to room air if resolved	NIV or HFNC post-extubation often required

✅ Section 8: Special Considerations

Status Asthmaticus, CO₂ Retainers, Cor Pulmonale, and Overlap Syndromes

🛑 1. Status Asthmaticus

A life-threatening asthma exacerbation that fails to respond to standard therapy (SABA + steroids). It requires immediate ICU management and possibly mechanical ventilation.

🔹 Key Features

Silent chest
Exhaustion, altered mental status
PaCO₂ normal or rising (warning sign)
Respiratory acidosis and hypoxia

🔹 Management Pearls

Early ketamine for bronchodilation and sedation
Magnesium sulfate 2 g IV over 20 minutes
Avoid intubation unless necessary – if required, use RSI with Ketamine + Rocuronium, and ventilate gently
Watch for auto-PEEP and dynamic hyperinflation
Sedate with Propofol, maintain bronchodilator therapy via in-line neb or MDI

🧠 This is a condition where aggressive ventilation can cause barotrauma if expiration is not fully allowed.

🌫️ 2. CO₂ Retainers (Mostly COPD)

Some COPD patients have chronically elevated PaCO₂, with their respiratory drive shifted to depend on hypoxia ("hypoxic drive").

🔹 Practical Guidelines

Aim for SpO₂ 88–92%, avoid high-flow oxygen unless needed
Sudden normalization of PaCO₂ is not required — permissive hypercapnia is safer
Monitor for CO₂ narcosis (confusion, drowsiness, pinpoint pupils)

🧠 Use ABG or transcutaneous CO₂ monitoring to assess effectiveness of NIV or invasive ventilation.

❤️ 3. Cor Pulmonale

Chronic hypoxia and pulmonary hypertension can lead to right heart failure in advanced COPD.

🔹 Signs:

Jugular venous distension
Lower limb edema
Hepatomegaly
Loud P2, right axis deviation on ECG
Echo: RV hypertrophy or dysfunction

🔹 Management

Treat exacerbation + consider diuretics cautiously
Avoid excessive PEEP (↓ venous return)
Monitor for fluid overload during resuscitation
Consider Pulmonary vasodilators in ICU if appropriate (e.g., inhaled nitric oxide or Sildenafil in rare cases)

🔄 4. Asthma-COPD Overlap (ACO)

Some patients, especially older smokers with allergic history, have features of both diseases.

🔹 Clues:

Reversible obstruction + eosinophilia + emphysema
History of childhood asthma + adult smoking
Good response to bronchodilators but frequent exacerbations

🔹 Management

Treat like asthma if eosinophilic and reversible
Use ICS + LABA as base
Add LAMA if COPD features dominate
Monitor closely postoperatively and during anesthesia — both airway reactivity and CO₂ retention risks coexist

🛌 5. Long-Term NIV and Home Oxygen

Many severe COPD patients are discharged with:

Home oxygen (for chronic hypoxemia — PaO₂ < 55 mmHg or SpO₂ < 88%)
NIV at home (for chronic hypercapnia or overlap with sleep apnea)

🔹 ICU Considerations:

Resume their own mask and machine if intubated and extubated
Avoid sudden withdrawal of NIV
Plan for step-down unit or pulmonary rehab referral

🧠 Coordinate with family, outpatient pulmonology, and discharge planning early.

🔁 Advanced ICU Strategy in COPD to Prevent Ventilator Dependency

🔹 Why Some COPD Patients Become Ventilator-Dependent

COPD patients may fail to wean due to:

Underlying severe airflow obstruction
CO₂ retention with poor respiratory drive
Weak respiratory muscles or critical illness myopathy
Repeated dynamic hyperinflation on each weaning attempt
Psychological dependence or depression
Delayed recognition of failed weaning trajectory

✅ Effective ICU Strategy to Prevent Ventilator Dependence

1️⃣ Early Use of NIV in Borderline Cases

NIV is first-line unless the patient is in arrest or severely encephalopathic
Try to avoid intubation unless absolutely necessary

2️⃣ Ventilate with COPD-Protective Strategy

Avoid excessive RR → allow long expiratory time
Avoid high PEEP unless matching auto-PEEP
Accept mild hypercapnia, prevent dynamic hyperinflation

3️⃣ Early Mobilization, Physio & Minimal Sedation

Avoid over-sedation → impairs drive, prolongs intubation
Daily trials of spontaneous breathing (PSV or CPAP)

4️⃣ Avoid Repeated Failed Extubation

Use clear weaning protocols, and if failure occurs twice:
⏳ Assess for tracheostomy

⏱️ When to Consider Tracheostomy in COPD

🔍 Early tracheostomy may be considered when:

Anticipated MV duration > 10–14 days
Failed ≥2 extubation trials
Unable to tolerate SBTs (Spontaneous Breathing Trials)
Severe CO₂ retention needing long-term support
High secretion load impairing extubation

🧠 Tracheostomy facilitates weaning, reduces sedation needs, allows better airway care and speech.

🔔 Common timeframe:
If no improvement after 10–14 days, and no reversibility expected, tracheostomy is recommended before 21 days to avoid complications of prolonged ETT.

💉 COPD and RSI: Special Considerations

🚨 Why RSI is Tricky in COPD

In a CO₂-retaining, acidotic COPD patient, intubation can be risky due to:

Sudden loss of spontaneous effort
Risk of dynamic hyperinflation post-paralysis
Worsened hypotension after induction
Inability to ventilate easily due to high resistance

✅ Modified RSI Strategy in COPD

Step	Strategy
Preoxygenation	Use NIV or BVM with PEEP valve to preoxygenate and de-nitrogenate
Induction agent	Etomidate (stable) or Ketamine (bronchodilator, maintains drive)
Muscle relaxant	Avoid unless necessary – if used, prefer Rocuronium over Sux
Ventilation	Small tidal volumes, long expiration, avoid aggressive BMV
Cricoid pressure	Apply only if needed – not mandatory in severe COPD
Sedation only	If not hypoxic, some prefer Ketamine-only intubation (no relaxant)

⚠️ Avoid This Mistake

Never use Succinylcholine in acidotic, hyperkalemic COPD unless ruled out — they often have electrolyte disturbances and muscle wasting.

🧠 Post-Intubation Pearls

Ventilate with 6 mL/kg TV, RR 10/min, I:E 1:4
Check auto-PEEP and plateau pressures
Place NG tube early to avoid gastric inflation
Monitor BP and perfusion — dynamic hyperinflation drops preload

✅ 🔄 Auto-PEEP in COPD & Asthma – Physiology, Detection, and Management

🔹 What is Auto-PEEP? (Intrinsic PEEP)

Auto-PEEP (also called intrinsic PEEP) is the residual positive pressure in the alveoli at the end of expiration — caused by incomplete lung emptying due to:

Air trapping
Increased airway resistance
Short expiratory time

This is common in:

Severe COPD
Status asthmaticus
High RR on ventilator
Patients with dynamic hyperinflation

🌬️ Why Is It Dangerous?

Increases intrathoracic pressure
Reduces venous return → hypotension
Increases work of breathing
Can lead to barotrauma (pneumothorax, pneumomediastinum)
Makes triggering the ventilator more difficult (patient has to overcome extra pressure to initiate breath)

📉 How to Detect Auto-PEEP

1️⃣ Flow-Time Curve

Look at expiratory flow:
🔸 If flow does NOT return to zero before next inspiration → there is auto-PEEP.

2️⃣ Expiratory Hold Maneuver

Performed on ventilator (in sedated/paralyzed patients):
🔸 Set an expiratory pause for 2–3 seconds
🔸 The ventilator measures total PEEP
🔸 Auto-PEEP = Total PEEP – Set PEEP

3️⃣ Clinical Signs

Hypotension after intubation
Difficulty triggering the ventilator
Tachycardia and high peak pressures
Breath stacking on auscultation

💡 Waterfall Analogy (How External PEEP Helps)

Imagine:

Airways in COPD are partially collapsed tubes
Air is trapped behind the collapse, like a pool of water behind a waterfall
If there's no external PEEP, air gets trapped and can't flow out

🔹 By applying external PEEP (usually 70–80% of measured auto-PEEP):

You “prop open” the collapsing airway
Air can drain more freely, like lowering the wall holding back the waterfall
This reduces work of breathing and improves ventilator synchrony

🧠 But if you apply PEEP that’s too high → you worsen air trapping and hyperinflation

🔧 How to Manage Auto-PEEP in Practice

🔹 Ventilator Settings

Goal	Setting Adjustment
Allow full exhalation	⬇️ RR (8–10 bpm), ⬆️ I:E (1:3 or 1:4)
Reduce tidal volume	Target 6–8 mL/kg
Avoid over-PEEP	Use 4–5 cmH₂O PEEP, match 75% of auto-PEEP
Measure regularly	Use expiratory hold once stabilized

🧠 Summary: Auto-PEEP in 5 Lines

Auto-PEEP = trapped pressure from incomplete exhalation
Confirm by flow not returning to zero or expiratory hold
Leads to dynamic hyperinflation → hypotension and poor synchrony
Manage with longer expiration, lower RR, and moderate external PEEP
Use PEEP to stent open airways – just enough to reduce effort, not too much

🔸 Footnote – Experimental Technique (Not Recommended for Routine Use):
In rare pediatric cases with severe air trapping, some clinicians have attempted manual chest compressions during exhalation (using both hands to gently assist passive expiration) to reduce auto-PEEP.
This technique is not supported by strong evidence, carries a risk of barotrauma, and should only be considered in highly monitored settings as a last resort. Standard ventilator strategies remain the cornerstone of safe management.

✅ Section 9: Pocket Guide & Clinical Pearls

Quick Reference for Asthma & COPD Management Across Settings

Designed for ICU rounds, anesthesia prep, emergency responses, and teaching, this section summarizes high-yield information from the guide in a concise, structured format.

📋 A. Asthma vs. COPD – Clinical Comparison

Feature	Asthma	COPD
Onset	Early life	>40 years
Reversibility	Fully or partially reversible	Irreversible or minimally reversible
Airflow Limitation	Intermittent	Progressive and persistent
Main Cells	Eosinophils, Th2	Neutrophils, CD8
DLCO	Normal or ↑	↓ in emphysema
Triggers	Allergens, exercise	Smoking, pollution
ICS Response	Strong	Variable

🧪 B. Acute Management Ladder (Simplified)

🫁 Acute Severe Asthma

O₂ (NRB or HFNC) → SpO₂ > 94%
Salbutamol + Ipratropium (q20 min)
IV steroids (Methylpred 60–125 mg)
IV MgSO₄ (2 g over 20 min)
SC Epinephrine (0.3–0.5 mg IM)
Ketamine (1 mg/kg) if crashing
Intubation only if impending arrest

🌫️ COPD Exacerbation

O₂ (Venturi mask) → SpO₂ 88–92%
Nebulized bronchodilators
IV/PO steroids (Methylpred 40–60 mg)
Antibiotics (if purulent sputum)
Trial of NIV
Intubate only if NIV fails

💉 C. Ventilator Settings at a Glance

Parameter	Asthma	COPD
Mode	VCV or PCV	PCV or VAC
TV	6 mL/kg	6–8 mL/kg
RR	8–10	10–12
I:E Ratio	1:3 to 1:5	1:3 to 1:4
PEEP	3–5 cmH₂O	Match 75% of auto-PEEP
FiO₂	Titrate > 92% (Asthma)	Titrate 88–92% (COPD)
Sedation	Often deep (Ketamine/Propofol)	Light to moderate

🧠 D. ICU Weaning and Tracheostomy Considerations

Trial of NIV before re-intubation
SBT failure x2 → consider tracheostomy
Prolonged MV >14 days → plan for trach before 21 days
Assess readiness with RSBI, ABG, CO₂ trend, secretions

🔧 E. Auto-PEEP Management Pearls

📈 Detect: Flow-time not returning to zero
🧪 Confirm: Expiratory hold = Auto-PEEP = Total – Set PEEP
⏳ Prevent: Low RR, long expiration (I:E ≥1:3), low TV
💧 Waterfall analogy: Small PEEP helps open collapsing airway to allow emptying
❌ Avoid: Excessive PEEP or high RR → worsens air trapping

🩺 F. Anesthesia Highlights

Step	Preferred in Asthma/COPD
Induction Agent	Ketamine or Propofol
Paralytic	Rocuronium (avoid histamine-releasers)
Inhalational	Sevoflurane > Isoflurane (avoid Des)
Ventilation	Long I:E, low RR, TV 6–8 mL/kg
Emergence	Consider deep extubation (Asthma only)
Pre-op Meds	SABA/SAMA + steroids 30–60 min pre-induction

✅ Section 10: MCQ Bank – Asthma & COPD

Q1. A 28-year-old asthmatic presents with severe dyspnea. RR 35, silent chest, SpO₂ 85% on NRB, and PaCO₂ is now 45 mmHg (was 28 two hours ago). What is the next best step?

A) Start antibiotics
B) Increase salbutamol frequency
C) Prepare for intubation
D) Give IV magnesium sulfate

✅ Correct Answer: C
Explanation: Rising PaCO₂ in a previously hyperventilating asthmatic indicates fatigue and impending respiratory failure — time to intubate.

Q2. Which of the following is the most appropriate initial FiO₂ target in a COPD exacerbation?

A) 100%
B) 94–96%
C) 88–92%
D) <85%

✅ Correct Answer: C
Explanation: Excessive FiO₂ can suppress the hypoxic drive and worsen hypercapnia. The safe target is SpO₂ 88–92%.

Q3. In mechanical ventilation of a COPD patient, which setting best prevents auto-PEEP?

A) High respiratory rate
B) Short inspiratory time
C) Long expiratory time
D) High PEEP (>10 cmH₂O)

✅ Correct Answer: C
Explanation: Long expiration allows trapped air to escape, minimizing dynamic hyperinflation.

Q4. Which inhaler combination is first-line for Group B COPD in GOLD guidelines?

A) LABA + ICS
B) LAMA alone
C) SABA PRN
D) LAMA + LABA

✅ Correct Answer: B
Explanation: Group B patients have high symptoms but low exacerbation risk — LAMA or LABA monotherapy is recommended.

Q5. What distinguishes COPD from asthma on spirometry?

A) Increased FEV₁ post-bronchodilator
B) Reversible obstruction
C) Fixed obstruction
D) Decreased FVC

✅ Correct Answer: C
Explanation: COPD is typically non-reversible or partially reversible airflow limitation.

Q6. What is the main risk of high-dose beta-agonist overuse in asthma?

A) Pulmonary edema
B) Hypokalemia and tachyarrhythmia
C) Hypernatremia
D) Bradycardia

✅ Correct Answer: B
Explanation: High-dose beta-agonists drive K⁺ into cells and increase catecholamine sensitivity.

Q7. Which of the following drugs is safest to use for induction in status asthmaticus?

A) Thiopental
B) Etomidate
C) Ketamine
D) Midazolam

✅ Correct Answer: C
Explanation: Ketamine has bronchodilatory effects and preserves airway reflexes — ideal in severe bronchospasm.

Q8. You suspect auto-PEEP in a ventilated patient. The best confirmatory maneuver is:

A) Inspiratory hold
B) Extubation and reintubation
C) Expiratory hold
D) Increase FiO₂ and observe

✅ Correct Answer: C
Explanation: Expiratory hold allows measurement of intrinsic (auto-)PEEP on the ventilator.

Q9. What’s the earliest sign of ventilator-induced dynamic hyperinflation?

A) Hypoxia
B) Increased peak inspiratory pressure
C) Flow not reaching baseline on expiratory curve
D) Tachycardia

✅ Correct Answer: C
Explanation: Incomplete return to zero on the flow-time curve = hallmark of air trapping.

Q10. A 65-year-old COPD patient intubated 10 days ago is failing weaning trials. What is the most appropriate next step?

A) Extubate anyway
B) Re-paralyze and rest lungs
C) Consider early tracheostomy
D) Start IV bronchodilators

✅ Correct Answer: C
Explanation: Persistent weaning failure >7–10 days warrants tracheostomy consideration to reduce complications.

Q11. What is the most appropriate post-extubation support in a COPD patient with chronic CO₂ retention?

A) Nasal cannula at 4 L/min
B) High-flow oxygen
C) NIV (BiPAP)
D) Room air

✅ Correct Answer: C
Explanation: NIV provides pressure support while avoiding hyperoxia-related CO₂ worsening.

Q12. In an asthmatic patient with worsening wheeze and anxiety, what clinical marker suggests impending respiratory failure?

A) Tachycardia
B) Normal PaCO₂
C) SpO₂ 95%
D) Expiratory wheeze

✅ Correct Answer: B
Explanation: A “normal” PaCO₂ is abnormal in tachypneic asthma — signals fatigue and poor ventilation.

Q13. Which medication is contraindicated as monotherapy in asthma due to risk of mortality?

A) ICS
B) LABA
C) SABA
D) LAMA

✅ Correct Answer: B
Explanation: LABA without ICS in asthma increases mortality risk. Must always pair with anti-inflammatory therapy.

Q14. A COPD patient on triple therapy presents with thick sputum and worsening dyspnea. What’s the next best step?

A) Increase LABA dose
B) Start empiric antibiotics
C) Give IV magnesium
D) Switch to DPI inhaler

✅ Correct Answer: B
Explanation: Sputum purulence + dyspnea = likely infectious trigger. Empiric antibiotics are warranted.

Q15. After ketamine-RSI intubation in an asthmatic patient, sudden hypotension occurs. Likely cause?

A) Hypovolemia
B) Allergic reaction
C) Dynamic hyperinflation
D) Inadequate paralysis

✅ Correct Answer: C
Explanation: Air trapping increases intrathoracic pressure → ↓ preload → hypotension. Always suspect this after intubating status asthmaticus.

📝 Final Words – Asthma & COPD Mastery Guide

For those who breathe to heal — and heal to help others breathe.

This guide was developed with dedication to all clinicians facing the daily challenge of managing asthma and COPD — from quiet outpatient corridors to the intensity of emergency rooms and ICU bedsides. These two chronic respiratory conditions, though common, demand uncommon vigilance, precision, and compassion.

Whether preparing a patient for surgery, calming a panicked child in status asthmaticus, or gently extubating an elderly man with end-stage emphysema — your role is pivotal.

🔹 In asthma, we control the fire before it burns through the airway.
🔹 In COPD, we preserve the lungs before they collapse under their own resistance.

Every setting is different — and so is every breath you protect.

🌍 To Those in Resource-Limited Settings

You may not always have Sevoflurane or high-flow oxygen. You may lack bronchoscopy, PFT labs, or blood gas machines.
But if you have clinical reasoning, if you listen to the chest, watch the waveform, and act on time —
you are enough.

🤝 Collaboration

Prepared for Dr. Amir Fadhel — Specialist in Anesthesiology and Critical Care,
in collaboration with Sophia (ChatGPT-4o).

This guide is part of the Mastery Series, designed to support clinicians, trainees, and students across various settings.
You can access all previously completed guides here:

🔗 Mastery Guide Series: https://justpaste.it/jkd89

🩺 Stay connected. Stay curious. Stay kind.

Breathe easy, think deeply, and lead with both knowledge and heart.

31/05/2025